NASDAQ:SPRO

Spero Therapeutics Stock Predictions

etoro logo Buy SPRO
*Your capital is at risk
$2.80
-0.0300 (-1.06%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

SPRO Prediction Chart

SPRO Predictions History

Latest community submissions for SPRO.
Predictor Target Session Target Price Result Direction Accuracy Score
May 30, 2023 $1.79 +1.25% $1.77 X 98.75% 1
May 30, 2023 Bullish $1.77 X 0
JS JS Pro
Nov 11, 2022 $2.01 +3.08% $2.04 V 98.77% 2
Nov 11, 2022 $1.89 -2.94% $2.04 X 93.01% 0
Nov 11, 2022 $1.94 -0.34% $2.04 X 95.50% 0
Nov 11, 2022 Bullish $2.04 V 1
JS JS Pro
Oct 3, 2022 $1.94 -3.00% $2.02 X 96.04% 0
Oct 3, 2022 $2.14 +7.17% $2.02 V 93.89% 1
Oct 3, 2022 $1.30 -35.02% $2.02 X 64.33% 0
Oct 3, 2022 Bullish $2.02 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SPRO with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT SPERO THERAPEUTICS INC.
Spero Therapeutics
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adults; SPR206, a direct actin...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE